View |
LRV2024-02-22-0064
|
DIPTHTHERIA, TETANUS, PERTUSSIS (ACELLULAR COMPONENT), POLIOMYELITIS (INACTIVATED) VACCINE AND HAEMOPHILUS INFLUENZAE TYPE B CONJUGATE VACCINE (ADSORBED) [DTaP-IPV AND HiB]
|
PENTAXIM
|
BR-523
|
X0C27
|
Packaging Lot (Box): X0C271V; (Vial [HiB]): W3H83; (Pre-filled Syringe [DTaP-IPV]): W3D93; (Needle 23G x 1"): 2202019; (Needle 25G x 5/8"): 2204036
|
30-Apr-25
|
28 February 2024
|
View |
LRV2024-02-22-0065
|
DIPHTHERIA, TETANUS, PERTUSSIS (ACELLULAR COMPONENT), AND POLIOMYELITIS (INACTIVATED) VACCINE (ADSORBED)
|
TETRAXIM
|
BR-518
|
W3D93
|
Packaging Lot (Box): W3D931V; (PFS): W3D93; (Needle 25G x 5/8"): 2204036; (Needle 23G x 1"): 2202013
|
30-Apr-25
|
29 February 2024
|
View |
2023-01-17-0024
|
PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (ADSORBED)
|
SYNFLORIX
|
BR-685
|
ASPNB362A
|
Packaging Lot (Box and Vial): ASPNB362AC; (Needle 25G x 1"): 2108045
|
30-Apr-26
|
20 January 2023
|
View |
2023-07-17-0229
|
INACTIVATED POLIOMYELITIS VACCINE (TYPES 1, 2 AND 3)
|
POLIOVAC
|
BR-1422
|
2443T009
|
Packaging Lot (Box and Vial): 2443T009
|
30-Apr-26
|
21 July 2023
|
View |
2023-07-17-0230
|
INACTIVATED POLIOMYELITIS VACCINE (TYPES 1, 2 AND 3)
|
POLIOVAC
|
BR-1422
|
2443T010
|
Packaging Lot (Box and Vial): 2443T010
|
30-Apr-26
|
20 July 2023
|
View |
2023-07-26-0249
|
HUMAN NORMAL IMMUNOGLOBULIN
|
IMMUNOREL
|
BRP-052
|
ID05G23028
|
Packaging Lot (Box and Vial): ID05G23028
|
30-Apr-26
|
01 August 2023
|
View |
2023-08-01-0268
|
HUMAN TETANUS IMMUNOGLOBULIN
|
IG TETANO
|
BR-801
|
P05R2023
|
Packaging Lot (Box and Pre-filled Syringe): P05R2023
|
30-Apr-26
|
08 August 2023
|
View |
2023-08-09-0275
|
HUMAN RABIES IMMUNOGLOBULIN
|
BERIRAB P
|
BR-869
|
P100566369
|
Packaging Lot (Box and PFS): P100566369; (Needle 21G x 1 1/2"): 1145480
|
30-Apr-26
|
11 August 2023
|
View |
2023-08-23-0282
|
PURIFIED VERO CELL RABIES VACCINE
|
ABHAYRAB
|
BR-629
|
23URAB037
|
Packaging Lot (Box and Vial): 23URAB037; (Diluent): SCSVBA0523; (Syringe): 2208501
|
30-Apr-26
|
29 August 2023
|
View |
2023-08-23-0283
|
PURIFIED VERO CELL RABIES VACCINE
|
ABHAYRAB
|
BR-629
|
23URAB036
|
Packaging Lot (Box and Vial): 23URAB036; (Diluent): SCSVBA0523; (Syringe): 2208501
|
30-Apr-26
|
29 August 2023
|
View |
LRV2023-09-26-0304
|
HUMAN RABIES IMMUNOGLOBULIN
|
BERIRAB P
|
BR-869
|
P100568492
|
Packaging Lot (Box and PFS): P100568492; (Needle 21G x 1 1/2"): 2087745
|
30-Apr-26
|
28 September 2023
|
View |
LRV2023-11-24-0380
|
TETANUS AND DIPHTHERIA TOXOIDS ADSORBED COMBINED WITH COMPONENT ACELLULAR PERTUSSIS VACCINE
|
ADACEL
|
BR-613
|
2CA74
|
Packaging Lot (Box and Vial): 2CA74C4
|
30-Apr-26
|
30 November 2023
|
View |
LRV2024-03-21-0108
|
RABIES VACCINE (INACTIVATED) (WISTAR STRAIN RABIES)
|
VERORAB
|
BR-220
|
X1A75
|
Packaging Lot (Box): X1A752V; (Vial): X1A75; (Syringe): X3H80
|
30-Apr-26
|
01 April 2024
|
View |
LRV2024-03-21-0109
|
RABIES VACCINE (INACTIVATED) (WISTAR STRAIN RABIES)
|
VERORAB
|
BR-220
|
X1A57
|
Packaging Lot (Box): X1A574V; (Vial): X1A57; (Syringe): X3H89
|
30-Apr-26
|
01 April 2024
|
View |
LRV2024-04-15-0134
|
TYPHOID POLYSACCHARIDE VACCINE
|
TYPHIM VI
|
BR-280
|
X2A45
|
Packaging Lot (Box): X2A451V; (PFS): X2A45
|
30-Apr-26
|
18 April 2024
|
View |
LRV2024-06-20-0248
|
TETANUS AND DIPHTHERIA TOXOIDS ADSORBED COMBINED WITH COMPONENT ACELLULAR PERTUSSIS VACCINE
|
ADACEL
|
BR-613
|
2CA90
|
Packaging Lot (Box and Vial): 2CA90C1
|
30-Apr-26
|
25 June 2024
|
View |
LRV2024-07-16-0307
|
HUMAN NORMAL IMMUNOGLOBULIN (IGIV)
|
GAMMA I.V.
|
BR-636
|
A03324010
|
Packaging Lot (Box and Vial): A03324010
|
30-Apr-26
|
22-Jul-24
|
View |
LRV2024-08-02-0343
|
BCG VACCINE
|
-
|
BR-572
|
0373G011
|
Packaging Lot (Box and Vial): 0373G011; (Diluent): 0703S4004
|
30-Apr-26
|
08 August 2024
|
View |
LRV2024-08-09-0370
|
EQUINE ANTI-RABIES IMMUNOGLOBULIN
|
VINRAB
|
BRP-090
|
08AR24029
|
Packaging Lot (Box and Vial): 08AR24029
|
30-Apr-26
|
14 August 2024
|
View |
LRV2024-08-22-0391
|
EQUINE ANTI-RABIES IMMUNOGLOBULIN
|
VINRAB
|
BRP-090
|
08AR24030
|
Packaging Lot (Box and Vial): 08AR24030
|
30-Apr-26
|
30-Aug-24
|